Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus\textendashHepatitis B Virus Co-infected Patients from Sub-Saharan Africa

Anders Boyd (1) , Laura Houghtaling (2) , Raoul Moh (3) , Mariama Abdou Chekaraou (4) , Delphine Gabillard (5, 6) , Serge Paul Eholié (3, 7, 8) , Xavier Anglaret (3, 5, 6) , Fabien Zoulim (4) , Christine Danel (3, 5, 6) , Karine Lacombe (9, 1)

1 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
2 UMN - University of Minnesota [Twin Cities]
3 Programme PAC-CI
4 UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon
5 BPH - Bordeaux population health
6 ISPED - Institut de Santé Publique, d'Epidémiologie et de Développement
7 CHU de Treichville - Centre Hospitalier Universitaire de Treichville [Abidjan, Côte d'Ivoire]
8 UFHB - Université Félix Houphouët-Boigny
9 CHU Saint-Antoine [AP-HP]

Domaines: Sciences du Vivant [q-bio]

Anders Boyd, Laura Houghtaling, Raoul Moh, Mariama Abdou Chekaraou, Delphine Gabillard, et al.. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus\textendashHepatitis B Virus Co-infected Patients from Sub-Saharan Africa. The American Journal of Tropical Medicine and Hygiene, 2017, 97 (6), pp.1936--1942. ⟨10.4269/ajtmh.16-1016⟩. ⟨hal-03704124⟩